## **Core Concept**
GLP-1 (Glucagon-like peptide-1) analogues are a class of medications used in the treatment of type 2 diabetes. They work by mimicking the action of the incretin hormone GLP-1, which is involved in glucose metabolism. Sulphonylureas, on the other hand, are a class of medications that stimulate insulin release from the pancreatic beta cells.

## **Why the Correct Answer is Right**
The correct answer, , highlights the advantage of GLP-1 analogues over sulphonylureas, which is their effect on weight. GLP-1 analogues promote weight loss or are weight-neutral, whereas sulphonylureas often lead to weight gain. This is because GLP-1 analogues slow gastric emptying, reduce appetite, and increase feelings of fullness, leading to reduced caloric intake. Additionally, GLP-1 analogues have been shown to have beneficial effects on cardiovascular risk factors and renal outcomes.

## **Why Each Wrong Option is Incorrect**
* **Option A:** - This option is incorrect because while GLP-1 analogues do have effects on gastric emptying and appetite, the primary advantage over sulphonylureas is not their mechanism of action on the stomach but rather their clinical effects, such as weight management and cardiovascular benefits.
* **Option B:** - This option is incorrect because although GLP-1 analogues do have benefits for cardiovascular health, stating they reduce cardiovascular events more than sulphonylureas can be complex and depends on the specific trial or study. However, it's not the most straightforward advantage related to the question.
* **Option C:** - This option is incorrect because while GLP-1 analogues do offer benefits in terms of glucose control, the question specifically asks for an advantage over sulphonylureas. Both classes can improve glucose control, but the manner and side effects differ.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that GLP-1 analogues, such as liraglutide and semaglutide, offer the benefits of weight loss and potential cardiovascular advantages, making them a favorable option for patients with type 2 diabetes who are overweight or have cardiovascular disease.

## **Correct Answer:** . Weight loss/neutrality